研究发现基因测试可以让许多乳腺癌患者避免化疗_公共英语阅读理解

研究发现基因测试可以让许多乳腺癌患者避免化疗

The majority of women with a common form of breast cancer may be able to skip chemotherapy after surgery, based on their score on a genetic test, researchers said.

研究人员表示，基于在基因检测中的得分，大多数患常见形式的乳腺癌的女性，可能可以在手术后跳过化疗。

As many as 65,000 women in the United States alone could be impacted by the study, released at the American Society of Clinical Oncology annual meeting in Chicago.

美国临床肿瘤学会在芝加哥举行的年度会议上公布，仅美国就有65000名妇女会受到这项研究的影响。

"With results of this ground-breaking study, we now can safely avoid chemotherapy in about 70 percent of patients who are diagnosed with the most common form of breast cancer," said co-author Kathy Albain, an oncologist at Loyola Medicine.

研究的合著者、洛约拉大学医学院的肿瘤学家凯西·阿尔班表示：“通过这项开创性的研究的结果，约70%的患有最常见乳腺癌类型的病人，可以安全地避免痛苦的化疗过程。”

研究发现基因测试可以让许多乳腺癌患者避免化疗1

"For countless women and their doctors, the days of uncertainty are over."

“对于无数女性和她们的医生而言，不明确的日子已经一去不复返了。”

A 21-gene test called Oncotype Dx that has been around since 2004 has helped guide some decisions, post-surgery. A high recurrence score, above 25, means chemo is advised to ward off a recurrence while a low score, below 10, means it is not.